| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 33,700 | 32,490 | 45,145 | 14,624 |
| Marketable securities | 1,042,542 | 709,665 | 635,118 | 646,428 |
| Inventory | 1,493 | 1,565 | 1,501 | NaN |
| Accounts receivable, net | 1,275 | 688 | 515 | NaN |
| Accounts receivable - other | NaN | NaN | NaN | 562 |
| Prepaid expenses and other current assets | 23,133 | 15,067 | 13,511 | 11,416 |
| Total current assets | 1,102,143 | 759,475 | 695,790 | 673,030 |
| Total property and equipment, cost | 17,368 | 17,070 | 15,952 | NaN |
| Less accumulated depreciation | 2,294 | 1,474 | 623 | NaN |
| Property and equipment, net | 15,074 | 15,596 | 15,329 | 253 |
| Operating lease right-of-use assets | 4,512 | 3,971 | 4,203 | 965 |
| Gross carrying amount | NaN | NaN | 1,700 | NaN |
| Accumulated amortization | NaN | NaN | 28 | NaN |
| Intangible assets, net | 560 | 575 | 1,672 | NaN |
| Goodwill | 10,297 | 10,297 | 12,805 | NaN |
| Note receivable, net | NaN | NaN | NaN | 26,675 |
| Other assets | 2,676 | 1,678 | 114 | 522 |
| Total assets | 1,135,262 | 791,592 | 729,913 | 701,445 |
| Accounts payable | 8,236 | 5,714 | 9,193 | 7,125 |
| Operating lease liabilities, current portion | 1,066 | 915 | 912 | 288 |
| Accrued expenses and other current liabilities | 25,914 | 24,207 | 20,423 | 22,968 |
| Total current liabilities | 35,216 | 30,836 | 30,528 | 30,381 |
| Long-term debt | 3,000 | 3,000 | 3,000 | NaN |
| Operating lease liabilities, net of current portion | 3,509 | 3,106 | 3,329 | 706 |
| Deferred tax liability | 307 | 307 | 1,609 | NaN |
| Other liabilities | 1,451 | 1,741 | 3,804 | NaN |
| Total liabilities | 43,483 | 38,990 | 42,270 | 31,087 |
| Common stock, 0.0001 par value per share 700,000,000 and 700,000,000 share authorized as of march 31, 2026 and december 31, 2025, respectively 88,007,761 and 80,689,128 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 9 | 8 | 8 | 8 |
| Additional paid-in capital | 1,530,948 | 1,131,570 | 1,025,302 | 964,209 |
| Accumulated deficit | -439,178 | -378,976 | -337,667 | -293,859 |
| Total stockholders' equity | 1,091,779 | 752,602 | 687,643 | 670,358 |
| Total liabilities and stockholders' equity | 1,135,262 | 791,592 | 729,913 | 701,445 |
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)